PDF-EXCELDrug Eluting Drug Eluting StentStentin Real World ExperienceM

Background Drugeluting stentsrepresent a major advance in the in the represent a major advance in the in the field of field of ofinterventional cardiology the interventional cardiology th. BY. M. AKRAM KHAN MD FACC FSCAI. . Financial Disclosure. None. WHY DRUG ELUTING BALLOON FOR SFA/POP DISEASE. PTA. High rate of restenosis (40 – 60%). DEBULKING DEVICE. High rate of restenosis / high rate of stent deployment. Robert Lookstein MD FSIR. Chief, Interventional Radiology . Mount Sinai Medical Center. Critical Limb Ischemia. Most severe form of Peripheral Arterial Disease (PAD).. Over . 100,000 . lower extremity amputations are performed in the United States (US) yearly for Critical Limb Ischemia.. resténose. . intra-stent. au ballon actif. Peeper. Pre-procedure. Post-procedure. 6-month. In-stent. Reference. vessel diameter. 2.84 ± 0.39mm. 2.86 ± 0.39mm. 2.82 ± 0.38mm. Minimum lumen diameter. January 15. th. , 2016. 10h30. What is/are the best antithrombotic treatment(s) in case of stent thrombosis?. A. ). . 75mg . of . clopidogrel. B). 150mg . of . clopidogrel. C). 90mg x 2 . of . ticagrelor. Second Generation Drug-eluting Stents Using. Either Biodegradable Polymer or Durable Polymer. The NOBORI . Biolimus. -Eluting versus . XIENCE/PROMUS . Everolimus. -eluting Stent Trial (NEXT). Masahiro . J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim, A. Schömig,. . A. Kastrati. . Deutsches Herzzentrum & 1st Med. Klinik rechts der Isar,. Technische Universität Munich,. Germany. ISAR-CABG:. Randomized, Superiority Trial of . vs. 1.46 mm, . p < 0.0001; . IVUS showed lower post-procedure mean lumen area in BVS arm (4.9 vs. 5.7 mm. 2. , . p < 0.001. ). 1-year scaffold thrombosis in . two . BVS . patients; . no stent thrombosis in DES arm. b. A. lloon. for in-stent . Re. stenosis). José PS Henriques, MD. Jan Baan, MD. Academic Medical Center . Amsterdam, The Netherlands. A randomized comparison of paclitaxel-eluting balloon* versus . Fig. 1.Initial, postprocedural and followup angiograms of case 1. A instent restenosis of the bare metal stent in the proximal left anterior descen - ding artery. B postprocedural angiogram after perf Individualizabledrug-eluting Stentsystemto Abrogate Restenosis)DESsystemallowson-sitecoatingofspeciallydesignedstentsconsistingof316Lmedicalstainlesssteelwitharelativelythinstrutthicknessof87mandamicr fact, the first BP stentwas made of polyesters. Poly(orthoesters), polyanhydrides, and polyphosphazenes are alsobeing actively investigated.DEGRADATION OF POLYMERSDegradation of polymers generally ref Zach Eddy, Category Advisor. 2. What are drug-eluting coronary stents?. Design. Expandable wire mesh tube. Coated with an antiproliferative drug. Pre-mounted on a balloon catheter delivery system. Function. Bioresorbable. Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population. Lisette Okkels Jensen, Michael . Maeng. , Bent . Raungaard. , Johnny . Kahlert. , Julia Ellert, Lars . Jakobsen. , . : The. . HOST. -Reduce-. Polytech. -. ACS. . trial. Hyo-Soo Kim, MD/PhD. Cardiovascular Center,. Seoul National University Hospital, Korea. Session of Late Breaking Trial Session IV. Co-sponsored by European Heart Journal.